Warburg Pincus X GP L.P.

CIK 1414564 · last filed 2020-05-07

Warburg Pincus X GP L.P. is a corporate insider who has filed 17 SEC Form 4 insider transactions across 9 companies since 2008. The most recent filing shows the insider sold $1.71B of SILK on May 7, 2020. Across all open-market trades the lifetime net is −$10.38B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.01B across reported positions. The firm reports its address in New York, NY. 191 SEC filings were submitted jointly with Warburg Pincus X, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.01B

Companies

9

Total Filings

17

Lifetime Open-Market Net

-$10.38B

Filer Profile

Reported Address
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY 10017
Phone
(212) 878-0600
State of Incorporation
DE
Formerly Known As
Warburg Pincus X LLC (2008–2014)
Related Filers
Warburg Pincus X, L.P. — 191 joint filings, latest 2021-04-15
PINCUS & CO. WARBURG — 174 joint filings, latest 2021-04-15
WARBURG PINCUS LLC — 155 joint filings, latest 2021-02-12
Warburg Pincus X Partners, L.P. — 145 joint filings, latest 2021-04-15
Warburg Pincus Private Equity X, L.P. — 144 joint filings, latest 2021-04-15
CHARLES R KAYE — 124 joint filings, latest 2020-01-14
Joseph P. Landy — 118 joint filings, latest 2019-11-13
Warburg Pincus Partners GP LLC — 77 joint filings, latest 2021-04-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Silk Road Medical Inc (SILK) Delisted 10%+ Owner 1,021,223 $27.49 $28.07M -$1.71B 1 2020-05-07
CRWD Director 310,000 $213.10 $66.06M -$3.54B 1 2019-12-11
AM Director 0 $22.60 $0 -$2.99B 1 2019-11-13
Triton International Ltd (TRTN) Delisted Director 0 $79.55 $0 -$2.22B 1 2019-04-08
MBI 10%+ Owner $4.77 $0 2 2015-02-09
NATIONAL PENN BANCSHARES INC (NPBC) Delisted Director 18,882,172 -$678.51M 1 2014-01-30
China Biologic Products, Inc. (CBPO) Delisted Director 10,989,200 $119.99 $1.32B $662.55M 2 2013-05-15
WBS 12,110,072 $77.57 $939.38M $61.88M 1 2010-01-04
BILL BARRETT CORP (BBG) Delisted 10%+ Owner 6,129,372 $42.35M 6 2008-12-11

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-05-07 Silk Road Medical Inc (SILK) Delisted Sell (S) −43,965,702 -$1.71B EDGAR
2019-12-11 CRWD Mixed -$3.54B EDGAR
2019-11-13 AM Sell (S) −459,308,740 -$2.99B EDGAR
2019-04-08 Triton International Ltd (TRTN) Delisted Sell (S) −71,327,900 -$2.22B EDGAR
2015-02-09 MBI Other (J) $0 EDGAR
2014-01-30 NATIONAL PENN BANCSHARES INC (NPBC) Delisted Sell (S) −63,000,000 -$678.51M EDGAR
2013-08-08 MBI Grant (A) $0 EDGAR
2013-05-15 China Biologic Products, Inc. (CBPO) Delisted Buy (P) +31,129,200 $622.58M EDGAR
2012-01-10 Grant (A) $0
2011-05-26 China Biologic Products, Inc. (CBPO) Delisted Buy (P) +2,632,284 $39.97M EDGAR
Showing 110 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.